These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 31185931

  • 1. Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.
    Jin L, Zhou J, Shao F, Yang F.
    BMC Nephrol; 2019 Jun 11; 20(1):213. PubMed ID: 31185931
    [Abstract] [Full Text] [Related]

  • 2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Jun 11; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 3. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug 11; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 4. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar 11; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

  • 5. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level.
    Chagnac A, Ori Y, Weinstein T, Zevin D, Korzets A, Hirsh J, Edelstein S, Gafter U.
    J Am Soc Nephrol; 1997 Oct 11; 8(10):1579-86. PubMed ID: 9335387
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low calcium dialysate and hyperparathyroidism.
    Duncan R, Cochrane T, Bhalla C, Michael J, Richards NT, Adu D.
    Perit Dial Int; 1996 Oct 11; 16 Suppl 1():S499-502. PubMed ID: 8728256
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K, Becker M, Marshall MR, Bühn S, Breuing J, Firanek CA, Hess S, Nariai H, Sloand JA, Yao Q, Chang TI, Chen J, Paniagua R, Takatori Y, Wada J, Pieper D.
    Am J Kidney Dis; 2020 Jun 11; 75(6):830-846. PubMed ID: 32033860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
    Yamamoto H, Kasai K, Hamada C, Hasegawa H, Higuchi C, Hiramatsu M, Hosoya T, Itami N, Kawanishi H, Kubota M, Masakane I, Minakuchi J, Mitarai T, Nakao T, Suzuki H, Tomo T, Kawaguchi Y, Japan Peritoneal Dialysis-Mineral Bone Disorders (PD-MBD) Research Group.
    Perit Dial Int; 2008 Jun 11; 28 Suppl 3():S128-30. PubMed ID: 18552242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.